Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway.

Sullivan NJ, Peterson M, Yang ZY, Kong WP, Duckers H, Nabel E, Nabel GJ.

J Virol. 2005 Jan;79(1):547-53.

2.

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ.

Nat Med. 2000 Aug;6(8):886-9.

PMID:
10932225
3.

Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein.

Francica JR, Matukonis MK, Bates P.

Virology. 2009 Jan 20;383(2):237-47. doi: 10.1016/j.virol.2008.10.029. Epub 2008 Nov 14.

4.

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P.

J Virol. 2002 Mar;76(5):2518-28.

5.

Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

Alazard-Dany N, Volchkova V, Reynard O, Carbonnelle C, Dolnik O, Ottmann M, Khromykh A, Volchkov VE.

J Gen Virol. 2006 May;87(Pt 5):1247-57.

PMID:
16603527
6.

Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.

Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE.

J Virol. 2009 Sep;83(18):9596-601. doi: 10.1128/JVI.00784-09. Epub 2009 Jul 8.

7.

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y.

Virology. 2000 Dec 5;278(1):20-6.

8.
9.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR.

Antiviral Res. 2003 Mar;58(1):47-56.

PMID:
12719006
10.

Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.

Dowling W, Thompson E, Badger C, Mellquist JL, Garrison AR, Smith JM, Paragas J, Hogan RJ, Schmaljohn C.

J Virol. 2007 Feb;81(4):1821-37. Epub 2006 Dec 6.

11.

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.

J Virol. 2006 Mar;80(6):2738-46.

12.

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.

Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P.

PLoS Pathog. 2010 Sep 9;6(9):e1001098. doi: 10.1371/journal.ppat.1001098.

13.

Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.

Marzi A, Wegele A, Pöhlmann S.

Virology. 2006 Sep 1;352(2):345-56. Epub 2006 Jun 13.

14.

Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.

Gustin JK, Bai Y, Moses AV, Douglas JL.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S181-90. doi: 10.1093/infdis/jiv125. Epub 2015 Mar 27.

PMID:
25821226
15.

Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.

Kaletsky RL, Simmons G, Bates P.

J Virol. 2007 Dec;81(24):13378-84. Epub 2007 Oct 10.

16.

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.

Volchkov VE, Volchkova VA, Muhlberger E, Kolesnikova LV, Weik M, Dolnik O, Klenk HD.

Science. 2001 Mar 9;291(5510):1965-9. Epub 2001 Feb 1.

18.

Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein.

Chepurnov AA, Tuzova MN, Ternovoy VA, Chernukhin IV.

Immunol Lett. 1999 Jun 1;68(2-3):257-61.

PMID:
10424429
19.

Epitopes required for antibody-dependent enhancement of Ebola virus infection.

Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S347-56.

20.

Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.

Usami K, Matsuno K, Igarashi M, Denda-Nagai K, Takada A, Irimura T.

Biochem Biophys Res Commun. 2011 Apr 1;407(1):74-8. doi: 10.1016/j.bbrc.2011.02.110. Epub 2011 Mar 6.

PMID:
21362405
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk